Skip to main content
CENTRE TESTING INTERNATIONAL GROUP CO., LTD. logo

CENTRE TESTING INTERNATIONAL GROUP CO., LTD. — Investor Relations & Filings

Ticker · 300012 ISIN · CNE100000GV8 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,101 across all filing types
Latest filing 2014-07-10 Capital/Financing Update
Country CN China
Listing Shenzhen Stock Exchange 300012

About CENTRE TESTING INTERNATIONAL GROUP CO., LTD.

https://www.cti-cert.com

Centre Testing International Group Co., Ltd. (CTI) is a comprehensive third-party agency specializing in testing, inspection, certification, and technical services. The organization provides a broad spectrum of solutions across diverse sectors, including consumer goods, electronics, environmental protection, food safety, life sciences, and industrial products. CTI's core capabilities encompass chemical and physical testing, safety assessments, and quality assurance. By leveraging an extensive network of laboratories and technical experts, the company assists global clients in meeting regulatory requirements, enhancing product quality, and managing supply chain risks. Its service portfolio also extends to sustainability consulting and carbon neutrality solutions, supporting businesses in achieving environmental and social governance goals through independent verification and technical support.

Recent filings

Filing Released Lang Actions
广东华商律师事务所关于公司调整以发行股份及现金方式购买资产并募集配套资金交易发行股份数量和发行价格的专项意见
Capital/Financing Update Classification · 95% confidence The document is a legal opinion issued by Guangdong Huashang Law Firm regarding adjustments to a transaction involving issuance of shares and cash to purchase assets and raise supporting funds by Shenzhen Huace Testing Technology Co., Ltd. It discusses changes in the number of shares issued and the issuance price, referencing relevant Chinese securities laws and regulations. The document is a specialized legal opinion related to a capital transaction, not a financial report, earnings release, or general announcement. It is not a full annual or interim report, nor a simple announcement of a report. It is also not a proxy statement, voting result, or management change notice. The content fits best under Capital/Financing Update (CAP) as it details adjustments to share issuance and fundraising related to a major asset purchase transaction.
2014-07-10 Chinese
平安证券有限责任公司关于公司变更部分超募资金用途暨投资新项目的核查意见
Capital/Financing Update Classification · 95% confidence The document is a detailed verification opinion from the sponsor institution (Ping An Securities) regarding the change in the use of part of the over-raised funds and investment in a new project by Shenzhen Huace Testing Technology Co., Ltd. It includes specifics about the original fundraising, the adjustment in fund usage, new project investment details, and the sponsor's verification opinion. The document references regulatory compliance and legal procedures but does not contain full financial statements or quarterly/yearly financial results. It is not an announcement of a report publication but a formal verification opinion related to fundraising and capital use. This fits best under Capital/Financing Update (CAP) as it deals with changes in the use of raised capital and investment projects, which is typical for CAP filings.
2014-07-10 Chinese
关于调整临床前CRO研究基地募投项目的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the adjustment of an investment project funded by raised capital (募投项目) by Shenzhen Huace Testing Technology Co., Ltd. It details changes in the allocation of funds within a previously approved project, including reasons for the adjustments and approvals by the board and supervisory committee. The document does not contain financial statements or comprehensive financial data but focuses on the use and adjustment of raised funds. It is not a full annual or interim report, audit report, or earnings release. It is also not a proxy statement or voting result announcement. The content fits the category of Capital/Financing Update (CAP), as it relates to updates on the use of fundraising proceeds and investment project adjustments.
2014-07-10 Chinese
独立董事提名人声明
Board/Management Information Classification · 95% confidence The document is a formal statement from the board of Shenzhen Huace Testing Technology Co., Ltd. nominating an independent director candidate, Zhang Hanbin. It details the candidate's qualifications, compliance with legal and regulatory requirements, and independence criteria. The content focuses on board nomination and director qualifications rather than financial results, audit, or shareholder voting outcomes. There is no indication of financial data, earnings, or report publication. The document is clearly related to board/management information, specifically the nomination of a board member.
2014-07-10 Chinese
独立董事候选人声明（张汉斌）
Board/Management Information Classification · 95% confidence The document is a detailed declaration by an independent director candidate of Shenzhen Huace Testing Technology Co., Ltd. It contains statements about the candidate's qualifications, independence, compliance with laws and regulations, and absence of conflicts of interest. There are no financial statements, earnings data, or corporate governance rules beyond the candidate's personal compliance. The document is not an announcement of a meeting, voting results, or a report on financial or management matters. It is a formal declaration related to board/management information, specifically concerning the appointment and qualifications of a board member. Therefore, the most appropriate classification is Board/Management Information (MANG). The document length and content support this classification with high confidence.
2014-07-10 Chinese
平安证券有限责任公司关于公司调整临床前CRO研究基地募投项目的核查意见
Capital/Financing Update Classification · 95% confidence The document is a verification opinion from the sponsor (Ping An Securities) regarding the adjustment of a fundraising investment project by Shenzhen Huace Testing Technology Co., Ltd. It discusses the use and adjustment of funds raised from an IPO, specifically the clinical CRO research base project. The document includes details about the fundraising amount, project investment adjustments, reasons for changes, and the sponsor's verification opinion. It is not a full financial report, earnings release, or management discussion, but rather a formal verification and opinion related to the use of raised funds. The document length is about 2200 characters, which is relatively short and focused on a specific fundraising project adjustment and verification. This fits best under Capital/Financing Update (CAP), as it relates to updates on fundraising and capital use. It is not an announcement of a report publication, nor a regulatory filing or audit report. Therefore, the classification is CAP with high confidence.
2014-07-10 Chinese

Browse filings by year

18 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.